Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Quantitation and characterization of serotype 6A activation for pneumococcal conjugate vaccine by cryo-EM and SEC methods.
Vaccine. 2024 Jun 24:S0264-410X(24)00709-6. doi: 10.1016/j.vaccine.2024.06.034. Online ahead of print.
Vaccine. 2024.
PMID: 38918102
Review.
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial.
Le Gars M, Sadoff J, Cárdenas V, Heerwegh D, Tesfaye F, Roey GV, Spicer C, Matias SS, Crayne O, Kamphuis T, Struyf F, Schuitemaker H, Douoguih M.
Le Gars M, et al.
Vaccine. 2024 Jun 24:S0264-410X(24)00401-8. doi: 10.1016/j.vaccine.2024.03.079. Online ahead of print.
Vaccine. 2024.
PMID: 38918103
Item in Clipboard
Winter 2022-23 influenza vaccine effectiveness against influenza-related hospitalised aLRTD: A test-negative, case-control study.
Chatzilena A, Hyams C, Challen R, Marlow R, King J, McGuinness S, Maskell N, Oliver J, Finn A, Danon L; AvonCAP Research Group.
Chatzilena A, et al.
Vaccine. 2024 Jun 24:S0264-410X(24)00713-8. doi: 10.1016/j.vaccine.2024.06.040. Online ahead of print.
Vaccine. 2024.
PMID: 38918104
No abstract available.
Item in Clipboard
Cite
Cite